Company Monitoring Page for JNJ

latest headlines for company on cafepharma

FDA experts offer a big thumbs up for J&J’s flawed application to market esketamine for major depression — but trial failures, safety questions spur concerns
Endpoints
Tue, 02/12/19 - 04:21 pm
Tags:
JNJ, FDA, advisory panels, esketamine, major depression
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
Yahoo/Benzinga
Sun, 02/10/19 - 11:08 pm
Tags:
Motif Biosciences, Iclaprim, Merck, Keytruda, melanoma, JNJ, esketamine, ASCO, Pfizer, Veru. earnings, Aveo Pharmaceuticals, Calithera Biosciences
Approving J&J's new depression drug would be an unusual move for the FDA
BioPharma Dive
Sun, 02/10/19 - 01:49 pm
Tags:
JNJ, esketamine, FDA, advisory panels
J&J’s Esketamine for Depression Faces an FDA Panel Next Week
BioSpace
Sat, 02/9/19 - 12:34 am
Tags:
JNJ, FDA, esketamine, major depression
Johnson & Johnson to be first drug maker to list prices in TV commercials
Stat
Thu, 02/7/19 - 03:32 pm
Tags:
JNJ, drug pricing, television ads
Powerful Senate committee invites pharma executives to testify
Reuters
Tue, 02/5/19 - 11:31 pm
Tags:
Senate, drug pricing, AbbVie, AstraZeneca, Bristol-Myers Squibb, JNJ, Merck, Pfizer, Sanofi
J&J, plaintiffs 'close' to deal on Pinnacle hip implant lawsuits: lawyer
Yahoo/Reuters
Tue, 02/5/19 - 10:07 am
Tags:
JNJ, DePuy, Pinnacle Hip, hip implants, metal-on-metal hip implants
Q4 Biopharma Themes: Strong 2018, Weaker 2019 Earnings Projections, Concerns over Drug Pricing
BioSpace
Fri, 02/1/19 - 11:27 am
Tags:
earnings, Pfizer, Amgen, AbbVie, JNJ, Merck, Novo Nordisk, Takeda
Philly jury hits J&J’s Ethicon with $41m judgment in pelvic mesh case
Mass Device
Thu, 01/31/19 - 11:58 pm
Tags:
JNJ, Ethicon, pelvic mesh, devices
J&J snags rights to a gene therapy portfolio from little MeiraGTx, a spinoff from Sam Waksal’s Kadmon
Endpoints
Thu, 01/31/19 - 11:46 am
Tags:
JNJ, MeiraGTx, gene therapy
FDA approves J&J’s Tremfya self-injection pen for psoriasis
Drug Delivery Business News
Wed, 01/30/19 - 06:52 pm
Tags:
JNJ, FDA, Tremfya, psoriasis
J&J scores another PhIII win for Erleada as it continues to build a blockbuster franchise
Endpoints
Wed, 01/30/19 - 11:47 am
Tags:
JNJ, Erleada, prostate cancer, metastatic prostate cancer
3 Big Pharmas Expecting a Softer 2019
Motley Fool
Wed, 01/30/19 - 09:50 am
Tags:
JNJ, AbbVie, Pfizer
Intuitive Surgical Clobbered On Mounting Expenses As J&J, Medtronic Loom
Investors Business Daily
Sat, 01/26/19 - 11:42 am
Tags:
devices, robotic surgery, Intuitive Surgical, Medtronic, JNJ
Amid controversies, J&J voted most admired pharma
Biopharma Dive
Thu, 01/24/19 - 11:46 pm
Tags:
JNJ
Does Johnson & Johnson's Grim Outlook Spell Trouble for Big Pharma Stocks?
Motley Fool
Thu, 01/24/19 - 11:47 am
Tags:
JNJ, Big Pharma, pharma stocks
J&J may nab surgical robotics company Auris Health
Mass Device
Wed, 01/23/19 - 07:46 pm
Tags:
devices, M&A, JNJ, Auris Health, robotic surgery
J&J CEO: We Know We Still Have More Work to Do [in Devices]
Medical Devices and Diagnostics Industry
Wed, 01/23/19 - 09:37 am
Tags:
JNJ, earnings, devices, Alex Gorsky
J&J, Attorneys General Settle Hip Implant Allegations for $120m
RAPS.org
Tue, 01/22/19 - 11:58 pm
Tags:
JNJ, DePuy, hip implants, metal-on-metal hip implants
Discounting hit J&J's Xarelto hard. Can a new launch turn things around?
Fierce Pharma
Tue, 01/22/19 - 11:56 pm
Tags:
JNJ, earnings, Xarelto

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.